Catherine Lee

1.9k total citations
8 papers, 256 citations indexed

About

Catherine Lee is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Catherine Lee has authored 8 papers receiving a total of 256 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 3 papers in Oncology and 3 papers in Genetics. Recurrent topics in Catherine Lee's work include Epigenetics and DNA Methylation (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer therapeutics and mechanisms (1 paper). Catherine Lee is often cited by papers focused on Epigenetics and DNA Methylation (2 papers), Lung Cancer Treatments and Mutations (2 papers) and Cancer therapeutics and mechanisms (1 paper). Catherine Lee collaborates with scholars based in United States, China and Australia. Catherine Lee's co-authors include Jeffrey H Miller, Hanjing Yang, Anya Salih, Robert M. Hoffman, Kyung Lee, Elinne Becket, William A. Weiss, Marc Zapatka, H. Leighton Grimes and Jianxun Wang and has published in prestigious journals such as Nature Communications, Gastroenterology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Catherine Lee

7 papers receiving 251 citations

Peers

Catherine Lee

MB

POLLU

MM

ONCOL

IMMUN

Baomo Liu China

Wuling Liu China

Yingping Cao China

Jessie Y.J. Bao China

Kelly Thornber United Kingdom

Anna Olsson Sweden

Dandan Wu China

Monika Pathak United Kingdom

D R Shaw United States

Kamila Chagas Peronni Brazil

Baomo Liu China

Catherine Lee

109 ×1.1

MB

25 ×0.3

POLLU

98 ×1.4

MM

87 ×1.4

ONCOL

19 ×0.4

IMMUN

Citations per year, relative to Catherine Lee Catherine Lee (= 1×) peers Baomo Liu

Countries citing papers authored by Catherine Lee

Since Specialization

Citations

This map shows the geographic impact of Catherine Lee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Catherine Lee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Catherine Lee more than expected).

Fields of papers citing papers by Catherine Lee

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Catherine Lee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Catherine Lee. The network helps show where Catherine Lee may publish in the future.

Co-authorship network of co-authors of Catherine Lee

This figure shows the co-authorship network connecting the top 25 collaborators of Catherine Lee. A scholar is included among the top collaborators of Catherine Lee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Catherine Lee. Catherine Lee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Jameson, Nathan M., Catherine Lee, Xiao Guo, et al.. (2025). The Selective WEE1 Inhibitor Azenosertib Shows Synergistic Antitumor Activity with KRAS G12C Inhibitors in Preclinical Models. Cancer Research Communications. 5(2). 240–252. 3 indexed citations

2.

Lee, Catherine, Ziyue Karen Jiang, Simon Planken, et al.. (2023). Efficacy and Imaging-Enabled Pharmacodynamic Profiling of KRAS G12C Inhibitors in Xenograft and Genetically Engineered Mouse Models of Cancer. Molecular Cancer Therapeutics. 22(7). 891–900.

3.

Stairiker, Christopher J., Sophia X. Pfister, Wenjing Yang, et al.. (2021). EZH2 Inhibition Compromises α4-1BB-Mediated Antitumor Efficacy by Reducing the Survival and Effector Programming of CD8+ T Cells. Frontiers in Immunology. 12. 770080–770080. 2 indexed citations

4.

Jia, Yongsheng, Krithika N. Kodumudi, Ganesan Ramamoorthi, et al.. (2021). Th1 cytokine interferon gamma improves response in HER2 breast cancer by modulating the ubiquitin proteasomal pathway. Molecular Therapy. 29(4). 1541–1556. 39 indexed citations

5.

Lee, Catherine, Vasilisa A. Rudneva, Serap Erkek, et al.. (2019). Lsd1 as a therapeutic target in Gfi1-activated medulloblastoma. Nature Communications. 10(1). 332–332. 65 indexed citations

6.

Becket, Elinne, Catherine Lee, Kyung Lee, et al.. (2011). Selective Advantage of Resistant Strains at Trace Levels of Antibiotics: a Simple and Ultrasensitive Color Test for Detection of Antibiotics and Genotoxic Agents. Antimicrobial Agents and Chemotherapy. 55(3). 1204–1210. 121 indexed citations

7.

Chang, Wei‐Kuo, Catherine Lee, H. Henry Lai, et al.. (2011). Safety and Tolerability of Physcion in Healthy Volunteers in a Phase I Dose Escalating Clinical Pharmacology Study. Gastroenterology. 140(5). S–572. 3 indexed citations

8.

Chin, Cynthia, et al.. (2003). Successful adoptive immunotherapy with vaccine-sensitized T cells, despite no effect with vaccination alone in a weakly immunogenic tumor model. Cancer Immunology Immunotherapy. 52(12). 739–750. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact